ישראל - עברית - Ministry of Health

bayer israel ltd - radium-223 dichloride - תמיסה להזרקה - radium-223 dichloride 1100 kbq/ml at reference date - radium (223 ra) dichloride

ישראל - עברית - Ministry of Health

neopharm (israel) 1996 ltd - ropivacaine as hydrochloride - תמיסה להזרקה - ropivacaine as hydrochloride 2 mg/ml - ropivacaine

ישראל - עברית - Ministry of Health

neopharm (israel) 1996 ltd - ropivacaine hydrochloride - תמיסה לאינפוזיה - ropivacaine hydrochloride 2 mg/ml - ropivacaine

ישראל - עברית - Ministry of Health

eldan electronic instruments co ltd, israel - gadoteric acid - תמיסה להזרקה - gadoteric acid 279.3 mg / 1 ml - gadoteric acid

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - salbutamol as sulfate - משאף - salbutamol as sulfate 100 mcg/dose - salbutamol - salbutamol - ventolin inhaler is a short-acting bronchodilator with fast onset in reversible airways obstruction. it is particularly suitable for the relief and prevention of asthma symptoms.it should be used to relieve symptoms when they occur, and to prevent them in those circumstances recognized by the patient to precipitate an asthma attack (e.g. before exercise or unavoidable allergen exposure).

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - salmeterol as xinafoate - אבקה לשאיפה - salmeterol as xinafoate 50 mcg - salmeterol - salmeterol - regular symptomatic add-on treatment of reversible airways obstruction in patients with asthma, including those with nocturnal asthma, who are inadequately controlled on inhaled corticosteroids in accordance with current treatment guidelines. treatment of chronic obstructive pulmonary disease (copd). prevention of exercise-induced asthma.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 80 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler is indicated in the regular treatment of asthma where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequaterly controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. - or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. note: symbicort turbuhaler 80/4.5 mcg/dose is not appropriate in patients with severe asthma.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 160 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - asthma symbicort turbuhaler is indicated in the regular treatment of asthma in adults and adolescents age 12 years and above where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. or - patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. copd symptomatic treatment of patients with severe copd (fev1 < 50 % predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular therapy with long-acting bronchodilators.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 320 mcg/dose; formoterol fumarate 9 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler is indicated in the regular treatment of asthma in adults and adolescents (over the age of 12 years) where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequaterly controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. - or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. copd symptomatic treatment of patients with severe copd (fev1 < 50 % predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular therapy with long-acting bronchodilators.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate; salmeterol as xinafoate - אבקה לשאיפה - fluticasone propionate 100 mcg; salmeterol as xinafoate 50 mcg - salmeterol and other drugs for obstructive airway diseases